How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients.

Objectives: The AsseSSing Impact in pSoriatic Treatment (ASSIST) study investigated prescribing in routine PsA care and whether the patient-reported outcome-PsA Impact of Disease questionnaire (PsAID-12)-impacted treatment. This study also assessed a range of patient and clinician factors and their relationship to PsAID-12 scoring and treatment modification.

Methods: Patients with PsA were selected across the UK and Europe between July 2021 and March 2022.

Level of Physical Activity and Knowledge about the Physical Activity Guidelines in a Group of Medical Residents from Puerto Rico.

Objective: Physicians who know about physical activity guidelines (PAG) and those who adhere to the PAG themselves may have a greater tendency to recommend physical activity (PA) to their patients. This study was aimed at evaluating the level of PA in a group of medical residents from Puerto Rico and to assess their knowledge regarding the PAG for adults.

Methods: A total of 104 medical residents from Puerto Rico completed a selfadministered questionnaire designed to obtain standardized estimates of their PA and to determine their level of knowledge regarding the PAG.

Intradialytic Hypertension / Hypotension and Mortality in San Juan, Puerto Rico.

End Stage Renal Disease patients undergo profound hemodynamic changes during hemodialysis treatments which are now recognized as a marker for increased risk of morbidity and mortality. Development of intradialytic hypotension or hypertension are a common clinical problem in this population with an incidence of up to 20%. We performed a retrospective review of 49 Hispanic patients receiving ambulatory hemodialysis during a period of 6 months to ascertain the development of aforementioned intradialytic events.

First-trimester aneuploidy screening: is there a maternal age at which it loses effectiveness?

Objective: To determine the maternal age at which the likelihood of a "screen-positive" result justifies diagnostic testing.

Study Design: A retrospective review of women who presented for first-trimester screening using nuchal translucency (NT) measurements with or without serum biochemistry between January 2000-December 2011. Using cutoffs of 1:300, 1:270, and 1:200, the Trisomy 21 (T21) screen-positive rates were stratified by maternal age.